EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
17 hedge funds and large institutions have $13.5M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
17
Holding in Top 10
–
Calls
$360K
Puts
–
Top Buyers
| 1 | +$3.21M | |
| 2 | +$1.91M | |
| 3 | +$1,000K | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$474K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$178K |
Top Sellers
| 1 | -$75.2K | |
| 2 | -$58.4K | |
| 3 | -$46.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$28.8K |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.4K |